|Bid||11.12 x 1400|
|Ask||11.59 x 800|
|Day's Range||10.46 - 10.77|
|52 Week Range||9.85 - 10.92|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 12, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
AMCI Acquisition Corp. (NASDAQ: AMCI) (the "Company") today announced that Advent Technologies ("Advent") – with which AMCI has entered into a definitive agreement and plan of merger for a business combination – recently reached an agreement to collaborate with Los Alamos National Labs, University of Texas at Austin (UT Austin), Rensselaer Polytechnic Institute (RPI), University of New Mexico and Toyota Motor North America R&D (TMNA R&D) to continue development of next-generation high-temperature polymer electrolyte membrane (HT-PEM) fuel cell technology for the automotive industry. The program is funded by an Advanced Research Projects Agency–Energy ("ARPA-E") OPEN award.
Advent Technologies, an innovation-driven company in the fuel cell and hydrogen technology space, today announced the appointment of Katherine E. Fleming as a new Member of its Board of Directors, in the context of its planned merger with AMCI Acquisition Corp (NASDAQ: AMCI) and the upcoming Nasdaq listing. Advent has recently announced a definitive agreement to merge with AMCI Acquisition Corp. (NASDAQ: AMCI) and become listed on the Nasdaq exchange. Dr. Fleming will join Advent’s board of Advisors immediately, and the board of directors appointment will commence upon the closing of the transaction.
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating AMCI Acquisition Corporation ("AMCI" or the "Company") (AMCI) relating to its proposed merger with Advent Technologies, Inc. Under the terms of the agreement, AMCI shareholders will own approximately 31% of the combined company.